The first mRNA flu shot is now available. Here’s who can get it.
Moderna's first mRNA flu vaccine has received FDA approval and is now available for older adults ahead of the 2026 flu season.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Moderna's mRNA flu vaccine received FDA approval and became available for adults 50 years and older. The shot was released ahead of the 2026 flu season.
Epilogue added 50d ago, after coverage quieted.
The brief
A new mRNA flu vaccine developed by Moderna has officially received approval from the FDA and is now available for public use. The rollout is strategically timed ahead of the 2026 flu season to provide an additional immunization option. According to reporting from Discover Magazine, KSBY News, and KSHB 41 Kansas City, the vaccine is currently approved specifically for adults who are 50 years of age and older. While the majority of outlets specify the age threshold as 50, reporting from kait8.com lists the eligible group as adults 55 and older. Extensive coverage of this development has appeared across a variety of news outlets, including Science News, which reports that the shot has hit its target.
Regional outlets such as PennLive.com and AL.com have highlighted the FDA approval process, while News-Medical emphasizes that the vaccine expands the existing protection options available to older adults. Additionally, WCAX and wcax.com report that medical professionals view the introduction of this mRNA-based option as a significant step forward for this year's vaccination efforts. This development represents a shift in flu vaccine technology, moving toward the mRNA platform previously used in other contexts. The timing is critical as the public prepares for the 2026 flu season, leading to consumer questions about timing. Syracuse.com reports that some individuals are asking doctors whether they should delay their standard flu shots to wait until they are eligible for this new mRNA version.
Jeffrey Kopin, who advises the public not to worry about the safety of the mRNA flu vaccine. Looking forward, the primary focus remains on the distribution and uptake of the shot among the eligible older adult population. Coverage does not yet specify if eligibility will be expanded to younger age groups in the future. Observers will likely monitor how this new option affects overall vaccination rates for the 2026 season. As noted by News-Medical, the current goal is to enhance flu protection specifically for the older demographic through this expanded set of medical options.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (94% supported) Updated 50d ago.
Quick answers
Who is eligible for the new mRNA flu vaccine?
According to most coverage, including Discover Magazine and KSBY News, the vaccine is approved for adults 50 years and older, though kait8.com specifies adults 55 and older.
Which company developed the vaccine?
The mRNA flu shot was developed by Moderna, as reported by Science News.
Has the vaccine been approved by the government?
Yes, PennLive.com and other outlets confirm the vaccine has received FDA approval.
Coverage (15)
- Moderna’s mRNA flu shot hits the target Science News · 58d ago
- A new mRNA flu vaccine just got FDA approval PennLive.com · 58d ago
- There's a new mRNA flu vaccine this year AL.com · 58d ago
- Dear Doctor: Should I hold off on my flu shot until I'm eligible for the new version? Syracuse.com · 58d ago
- Dr. Roach: Natural CMV immunity isn't fully protective against reinfection STLtoday.com · 58d ago
- First mRNA Flu Vaccine Approved in the U.S. Now Available for Adults 50 Years and Older Discover Magazine · 58d ago
- New mRNA flu vaccine approved for adults 50 and older ahead of flu season KSBY News · 58d ago
- Flu season 2026: New MRNA vaccine option for adults 50 and older K8 News | Jonesboro, Arkansas · 58d ago
- Flu season 2026: New MRNA vaccine option for adults 55 and older kait8.com · 58d ago
- Dr. Jeffrey Kopin: Don’t worry about safety of mRNA flu vaccine WGN Radio 720 · 58d ago
- New mRNA flu vaccine approved for adults 50 and older ahead of flu season Scripps News · 58d ago
- New mRNA flu vaccine approved for adults 50 and older ahead of flu season KSHB 41 Kansas City · 58d ago
- Doctors call new mRNA flu shot a step forward this season WCAX · 58d ago
- Doctors call new mRNA flu shot a step forward this season wcax.com · 58d ago
- New mRNA vaccine expands flu protection options for older adults News-Medical · 58d ago
Topics
Related trends
Rabies clinic planned after cat tests positive in south-central Kansas
A rabies clinic is being organized in south-central Kansas following a confirmed feline rabies case in the Benton area.
FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class
The United States Food and Drug Administration has rejected Summit Therapeutics and Akeso's lung cancer drug ivonescimab.
World Diabetes Day 2026: Prediabetes Is Your Window To Act, Simple Ways To Reverse The Condition
World Diabetes Day 2026 spotlights prediabetes as a critical intervention window, with coverage from five outlets across three continents warning millions remain undiagnosed.
Surging measles cases are forcing doctors to treat conditions they’ve never seen
The United States has lost its measles elimination status after 26 years as cases surge to 5,412 and the death toll reaches 10 in 2026.
U.S. loses measles-elimination status, erasing a landmark public health achievement
The United States has lost its measles-elimination status after 26 years, marking a major reversal in public health progress.
The US flu season is off to a very early start. It’s targeting the South and West now
The United States flu season is off to a very early start, with high or very high activity targeting regions in the South and West.